Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey

被引:32
|
作者
Abitbol, Vered [1 ]
Lahmek, Pierre [3 ]
Buisson, Anne [2 ]
Olympie, Alain [2 ]
Poupardin, Cecile [4 ]
Chaussade, Stanislas [1 ]
Lesgourgues, Bruno [4 ]
Nahon, Stephane [4 ]
机构
[1] Cochin Hosp, APHP, Dept Gastroenterol, F-75014 Paris, France
[2] Assoc Francois Aupetit, Limeil Brevannes, France
[3] Emile Roux Hosp, APHP, Limeil Brevannes, France
[4] GHI Le Raincy Montfermeil, Dept Gastroenterol & Hepatol, Montfermeil, France
关键词
adherence; complementary and alternative medicines; compliance; Crohn's disease; quality of life; ulcerative colitis; ADHERENCE; CARE; PREDICTORS; MEDICATION; MANAGEMENT; QUESTIONNAIRE;
D O I
10.1097/MEG.0000000000000040
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundComplementary and alternative medicines (CAM) are widely used by patients with inflammatory bowel disease (IBD). Few data have been published on the impact of CAM on the quality of life (QOL).AimsThe aim of the study was to describe CAM use in French patients with IBD, identify characteristics associated with CAM use, and assess the impact of CAM on the QOL.MethodsWe conducted an internet survey on CAM through the French IBD patient's association website. Patients had to answer a questionnaire (LimeSurvey application) about sociodemography, IBD treatment, CAM type, socioeconomic data, and QOL using the Short IBD Questionnaire (SIBDQ). Patients noted the impact of CAM on their symptoms and on their QOL on a scale of 0-100. CAM users and nonusers were compared by univariate and multivariate analyses.ResultsA total of 936 IBD patients responded and 767 (82.4%) filled up the whole questionnaire: 503 reported CAM use and 172 had never used. The types of CAM reported were diet-based (30.7%), body-based (25.1%), homeopathic or traditional medicine (19.6%), naturopathy (15.2%), and mind-body medicine (9.1%). The gastroenterologist was aware of CAM use in only 46% of patients. CAM users were more likely to have ulcerative colitis [odds ratio (OR)=1.78, P=0.018], clinical remission (OR=1.42, P=0.06), high level of education (OR=1.51, P=0.02), poor observance (OR=1.81, P=0.017), or to have terminated conventional treatment (OR=2.03, P=0.003). CAM users tend to have higher rates of SIBDQ scores, greater than 50 (OR=1.57, P=0.06). Improvement in symptoms and QOL was reported with all CAM types except mind medicine.ConclusionCAM use is widespread among IBD patients. CAM users report improvement in symptoms and QOL, but they tend to stop their conventional treatment. Better information about CAM might improve adherence to conventional treatment.
引用
收藏
页码:288 / 294
页数:7
相关论文
共 50 条
  • [1] Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease
    Kutschera, Maximilian
    Waldhoer, Thomas
    Groechenig, Hans Peter
    Haas, Thomas
    Wenzl, Heimo
    Steiner, Pius
    Koch, Robert
    Feichtenschlager, Thomas
    Eckhardt, Gerald
    Mayer, Andreas
    Kirchgatterer, Andreas
    Ludwiczek, Othmar
    Platzer, Reingard
    Papay, Pavot
    Gartner, Johanna
    Fuchssteiner, Harry
    Peters, Paul-Gerhard
    Reicht, Gerhard
    Moser, Gabriele
    Dejaco, Clemens
    Vogelsang, Harald
    Primas, Christian
    Novacek, Gottfried
    Miehsler, Wolfgang
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (01) : 72 - 81
  • [2] Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile
    Fernandez, Antonia
    Simian, Daniela
    Quera, Rodrigo
    Flores, Lilian
    Ibanez, Patricio
    Lubascher, Jaime
    Figueroa, Carolina
    Kronberg, Udo
    Pizarro, Gonzalo
    Fluxa, Daniela
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 40 : 77 - 82
  • [3] Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002
    Bauer, Nina
    Kairey, Lana
    Schlee, Christoph
    Uecker, Christine
    Oeznur, Oezlem
    Langhorst, Jost
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 1209 - 1215
  • [4] Disease impact on the quality of life of children with inflammatory bowel disease
    Chouliaras, Giorgos
    Margoni, Daphne
    Dimakou, Konstantina
    Fessatou, Smaragdi
    Panayiotou, Ioanna
    Roma-Giannikou, Eleftheria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (06) : 1067 - 1075
  • [5] Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease
    Groechenig, Hans Peter
    Waldhoer, Thomas
    Haas, Thomas
    Wenzl, Heimo
    Steiner, Pius
    Koch, Robert
    Feichtenschlager, Thomas
    Eckhardt, Gerald
    Mayer, Andreas
    Kirchgatterer, Andreas
    Ludwiczek, Othmar
    Platzer, Reingard
    Papay, Pavol
    Gartner, Johanna
    Fuchssteiner, Harry
    Miehsler, Wolfgang
    Peters, Paul-Gerhard
    Reicht, Gerhard
    Kutschera, Maximilian
    Dejaco, Clemens
    Vogelsang, Harald
    Novacek, Gottfried
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1211 - 1219
  • [6] Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey
    Fumiaki Ueno
    Yasuo Nakayama
    Eiji Hagiwara
    Sarina Kurimoto
    Toshifumi Hibi
    Journal of Gastroenterology, 2017, 52 : 555 - 567
  • [7] Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey
    Ueno, Fumiaki
    Nakayama, Yasuo
    Hagiwara, Eiji
    Kurimoto, Sarina
    Hibi, Toshifumi
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (05) : 555 - 567
  • [8] Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease -: Results from a German national survey
    Langhorst, J
    Anthonisen, IB
    Steder-Neukamm, U
    Lüdtke, R
    Spahn, G
    Michalsen, A
    Dobos, GJ
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (03) : 287 - 295
  • [9] Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway
    Opheim, Randi
    Bernklev, Tomm
    Fagermoen, May Solveig
    Cvancarova, Milada
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (12) : 1436 - 1447
  • [10] Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease
    Weizman, A. V.
    Ahn, E.
    Thanabalan, R.
    Leung, W.
    Croitoru, K.
    Silverberg, M. S.
    Steinhart, A. Hillary
    Nguyen, G. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) : 342 - 349